Bisphosphonate as a potential new treatment for CV risk reduction - PACE-CME

Bisphosphonate as a potential new treatment for CV risk reduction

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Possible approaches in precision medicine for secundary CV prevention
Possible approaches in precision medicine for secundary CV prevention
CSI 2016 ESC
Possible approaches in precision medicine for secundary CV prevention
- Dr. Noel Bairey Merz
What can new glucose-lowering SGLT2-inhibitors add to CV risk management in diabetes?
What can new glucose-lowering SGLT2-inhibitors add to CV risk management in diabetes?
CSI 2016 ESC
What can new glucose-lowering SGLT2-inhibitors add to CV risk management in diabetes?
- Prof. Silvio E Inzucchi
To SPRINT or not to SPRINT to a lower blood pressure target?
To SPRINT or not to SPRINT to a lower blood pressure target?
CSI 2016 ESC
To SPRINT or not to SPRINT to a lower blood pressure target?
A minority of FH patients is identified and labeled as such, which impacts treatment
A minority of FH patients is identified and labeled as such, which impacts treatment
CSI 2016 ESC
A minority of FH patients is identified and labeled as such, which impacts treatment
- Prof Kausik Ray